- A CARD9 founder mutation disrupts NF-κB signaling by inhibiting BCL10 and MALT1 recruitment and signalosome formation(2018)
Auteurs: Marieke De Bruyne, Levi Hoste, Delfien Bogaert, Lien Van den Bossche, Eef Parthoens, Mélanie Migaud, Deborah Konopnicki, Jean Cyr Yombi, Ana Alves de Medeiros, Lieve Brochez, et al.
- Managing psoriasis anno 2018 : a route towards personalising treatment(2018)
Auteurs: Ana Alves de Medeiros
- Chronic and invasive fungal infections in a family with CARD9 deficiency(2016)
Auteurs: Ana Alves de Medeiros, EVELYNE LODEWICK, Delfien Bogaert, Filomeen Haerynck, Sarah Bosma, Laure Vanderdonckt, Olivier Lortholary, Mélanie Migaud, Jean-Laurent Casanova, Anne Puel, et al.
Pagina's: 204 - 209
- JAK3 as an emerging target for topical treatment of inflammatory skin diseases(2016)
Auteurs: Ana Alves de Medeiros, Reinhart Speeckaert, Eline Desmet, Mireille Van Gele, Sofie De Schepper
- A multileveled approach in psoriasis assessment and follow-up : a proposal for a tailored guide for the dermatological practice
Auteurs: Eveline DeCoster, Ana Alves de Medeiros, Jessica Bostoen
Pagina's: 298 - 310
- Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate-to-severe psoriasis
Auteurs: Mireille Van Gele, Stefanie Bracke, Ana Alves de Medeiros
Pagina's: 195 - 198
- STAT3 as a therapeutic target for the treatment of atopic dermatitis and pyoderma gangrenosum
Volume: 135
Auteurs: Ana Alves de Medeiros, Sofie De Schepper
Pagina's: S16 - S16
- Immunohistochemical analysis of the JAK family members in inflammatory skin diseases reveals increased expression of JAK1 and JAK3
Volume: 135
Auteurs: Ana Alves de Medeiros, Sofie De Schepper
Pagina's: S12 - S12
- PsoPlus, a comprehensive consultation programme for psoriasis
Volume: 135
Auteurs: Eline De Keyser, E De Coster, Ana Alves de Medeiros, Elfie Deprez
Pagina's: S16 - S16